
Less than 1 month remains for physicians to file a claim for the $350 million settlement reached against UnitedHealth Group and its Ingenix subsidiary for its flawed out-of-network reimbursement database.

Less than 1 month remains for physicians to file a claim for the $350 million settlement reached against UnitedHealth Group and its Ingenix subsidiary for its flawed out-of-network reimbursement database.

In men with localized prostate cancer, high-intensity focused ultrasound (HIFU) offers a rate of cancer-specific survival at 8 years similar to that expected with external beam radiation therapy, French researchers reported.

Every newborn child should be screened for congenital adrenal hyperplasia (CAH) and positive results should be followed by testing, according to a new clinical practice guideline from the Endocrine Society on the diagnosis and treatment of the condition.

In men with a low serum baseline PSA level, the benefits of additional screening or treatment appear to be, European researchers reported.

UCLA scientists say they have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostic tools and the development of more effective targeted treatments for the disease.

Short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives, according to a recent study.

Men exposed in the womb to the pesticide dichlorodiphenyltrichloroethane (DDT) and its related compounds are more likely to develop testicular cancer, say researchers from Child Health and Development Studies (CHDS), Berkeley, CA.

Men using commonly prescribed medications?nonsteroidal anti-inflammatory drugs, statins, and thiazide diuretics?appear to experience reduced PSA levels by clinically significant amounts, researchers from Stanford University, Stanford, CA recently reported.

A 17-year population study in Minnesota uncovered suggestions that the rate of decline in testosterone levels may play a role in the rate at which BPH increases and urinary flow decreases, but the associations are far from clear.

Implementation of the "Red Flags Rule" by the Federal Trade Commission, which would require medical practices and other businesses to take specific steps to minimize identity theft and which has been challenged by the AUA, has been delayed until a federal appeals court rules on a lawsuit by the American Bar Association.

Most urologists are concerned about radiation exposure from CT scans, and many have begun to consider more carefully the relative risks and benefits of CT and other imaging techniques.

In this article, we discuss the evolution of mid-urethral sling kits, outline the advantages and disadvantages of three distinct approaches to MUS placement, and provide an overview of our algorithm for procedure selection.

In an era in which we increasingly strive to optimize men's health, an understanding of the complex interaction of medical therapies designed to improve voiding (alpha-blockers and 5-alpha-reductase inhibitors), sexual function (testosterone), and lipid metabolism (statins) will be better described.

A newer selective alpha-1 blocker provided statistically significant reductions in BPH symptom scores compared with placebo and was well tolerated in a study from several European institutions.

With real-time claims adjudication, a patient receives a service in your office and then in real time, while the patient is in the office, she receives an explanation of benefits that details her charges, what the insurance company allows, the amount of the co-pay, and the status of the patient's deductible.

Unlike PSA, the PCA3 assay can identify prostate biopsy outcomes even in men taking a 5-alpha-reductase inhibitor.

Five-alpha-reductase inhibitors may do more than treat BPH and reduce prostate cancer risk; they may ease chronic prostatitis/chronic pelvic pain syndrome symptoms.

Researchers in Colorado found no relationship between total testosterone and lower urinary tract symptoms in what may be the largest cross-sectional study of the association to date.

Make sure that the requesting partner has clear documentation of the request for determination of whether the consulting physician should take over care of the patient, and make sure the consulting physician documentation is clear on the request for determination of care.

In men with metastatic castration- resistant prostate cancer who progressed after docetaxel (Taxotere)-based therapy, treatment with cabazitaxel (Jevtana) was associated with significantly better overall survival compared with mitoxantrone (Novantrone).

The newest urology products and services.

After brachytherapy, 81.3% of men responding to a survey reported successful ejaculation and 90% reported successful orgasm. But the number of men reporting rare ejaculation or no ejaculation at all doubled.

Urologists already often refer to specialists for pain issues.

Diversification gives investors a valuable tool for managing risk and volatility in an investment portfolio. Effective diversification, however, requires diligent maintenance.

Urology drugs and devices that are in the pipeline.

"Lean management" is the latest buzz phrase among savvy medical practices that are trying to reduce costs while improving quality.

Researchers have shed new light on the questionable relationships among prostatitis/chronic pelvic pain syndrome, depression, sexual dysfunction, and lower urinary tract symptoms.

Although active surveillance is not a popular option for men with low-risk prostate cancer, the majority of those who choose it are satisfied with their selection.

Two-year progression-free survival improved significantly in men with castration-resistant prostate cancer treated with toremifene.

Postoperative statin use may offer a potential therapeutic benefit in men with prostate cancer who undergo radical prostatectomy.